Target intelligence / Profile preview

Monkeypox virus A35R protein (A35R)

Target
A35R
Molecular classification
Viral envelope glycoprotein, Other
01

Overview

The Monkeypox virus A35R protein is a transmembrane envelope glycoprotein expressed on the enveloped virion (EV) form of the virus, homologous to vaccinia virus A33R, and plays a critical role in poxvirus replication and pathogenesis. It facilitates the formation of actin-containing microvilli on infected cells, enabling efficient cell-to-cell spread of viral particles, and coordinates incorporation of other viral proteins into EV membranes as part of a complex with OPG162 and OPG190. Loss of A35R results in 1000-fold attenuation of viral virulence, underscoring its importance in infection. In monkeypox disease, A35R contributes to viral transmission and dissemination, making it a key player in orthopoxvirus infections like mpox outbreaks. Recent studies have identified high-affinity human monoclonal antibodies (e.g., EV35-2, EV35-6, EV35-7, mAb981) that bind a highly conserved epitope on A35R, blocking viral spread in vitro and protecting mice from lethal challenge via both Fc-dependent and independent mechanisms; elevated natural A35R-specific antibodies in convalescent sera correlate with better clinical outcomes. Crystal structures of A35R-antibody complexes reveal structural vulnerabilities exploitable for therapies, positioning A35R as a promising therapeutic target for next-generation orthopoxvirus treatments due to its conservation across poxviruses.

Other names
A35 proteinA35OPG161VACV A33R homolog
02

Mechanism of action

Neutralization of viral spread via binding to conserved epitope on A35R (Fc-dependent and Fc-independent), Blockade of enveloped virion transmission

03

Biological functions

Viral virulenceCell-to-cell spread of virusVirion envelopmentActin microvilli formation
04

Disease associations

Infection
05

Interacting drugs

EV35-2 monoclonal antibody

3 more in the full profile.

06

Biomarkers

Serum antibodies targeting A35R epitope (higher levels associated with milder disease, shorter symptom duration, reduced hospitalization)

Beyond the preview

Go deeper on Monkeypox virus A35R protein (A35R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monkeypox virus A35R protein (A35R).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call